We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical tri... Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. Show more
- In the Phase 2 PRECEDENT Study, dalzanemdor (SAGE-718) did not show statistically significant differences versus placebo on the primary endpoint in patients with mild cognitive impairment in...
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that it will host a live webcast on Thursday, April...
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.625 | -21.7587034814 | 16.66 | 16.81 | 10.92 | 1852062 | 14.22147675 | CS |
4 | -6.645 | -33.7652439024 | 19.68 | 20.32 | 10.92 | 1005550 | 16.05506805 | CS |
12 | -13.805 | -51.4344262295 | 26.84 | 27.675 | 10.92 | 987120 | 20.62263244 | CS |
26 | -6.775 | -34.1998990409 | 19.81 | 28.26 | 10.92 | 939240 | 21.00117533 | CS |
52 | -32.965 | -71.6630434783 | 46 | 59.99 | 10.92 | 1074634 | 26.21054362 | CS |
156 | -61.475 | -82.5057039324 | 74.51 | 80.87 | 10.92 | 763358 | 35.13686683 | CS |
260 | -148.395 | -91.9252926965 | 161.43 | 193.56 | 10.92 | 750302 | 50.31553989 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions